DOULEUR ET PERSONNE ÃGÃE - Institut upsa de la douleur
DOULEUR ET PERSONNE ÃGÃE - Institut upsa de la douleur
DOULEUR ET PERSONNE ÃGÃE - Institut upsa de la douleur
- No tags were found...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
32. McCarberg BH. Rheumatic diseases in the el<strong>de</strong>rly: <strong>de</strong>aling with rheumatic painin exten<strong>de</strong>d care facilities. Rheum Dis Clin North Am. 2007;33:87-108.33. Mejjad O, Vittecoq O. Traitement <strong>de</strong> l’arthrose <strong>de</strong>s patients agés. Presse Med 2000 ;29:2157-61.34. Mukherjee D., Nissen S.E., Topol E.J. Risk of cardiovascu<strong>la</strong>r events associatedwith selective COX-2 inhibitors. JAMA 2001 ;286 : 954-959.35. Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, et al. Opioids and themanagement of chronic severe pain in the el<strong>de</strong>rly: consensus statement of anInternational Expert Panel with focus on the six clinically most often used WorldHealth Organization Step III opioids (buprenorphine, fentanyl, hydromorphone,methadone, morphine, oxycodone). Pain Pract. 2008;8:287-313.36. Perrot S, Menkes CJ. Nonpharmacological approaches to pain in osteoarthritis.Avai<strong>la</strong>ble options. Drugs. 1996;52 Suppl 3:21-6.37. Podichetty VK, Mazaneck D, Biscup RS. Chronic nonmalignant musculoskeletal painin ol<strong>de</strong>r adults: clinical issues and opiod intervention. Post Grad Med Journal.2003;79: 627–633.38. Reid MC, Papaleontiou M, Ong A, Breckman R, Wethington E, Pillemer K.39. Rowbotham, M., Har<strong>de</strong>n, N., Stacey, B., Bernstein, P., & Magnus-Miller, L. Gabapentinfor treatment of postherpetic neuralgia: a randomized controlled trial. JAMA 1998 ;280 : 1837-1842.40. Schiodt F.V., Rochling F.A., Casey D.L., Lee W.M. Acetaminophen toxicityin an urban county hospital. NEJM 1997 ; 337 :1112-1117.Self-management strategies to reduce pain and improve function among ol<strong>de</strong>radults in community settings: a review of the evi<strong>de</strong>nce. Pain Med 2008;9:409-24.41. Shimp LA. Safety issues in the pharmacologic management of chronic pain in theel<strong>de</strong>rly. Pharmacotherapy 1998; 18: 1313-22.42. Stanczak J, B<strong>la</strong>nkenbaker DG, De Smet AA, Fine J. Efficacy of epidural injections ofKenalog and Celestone in the treatment of lower back pain. AJR 2003;181:1255-8.43. Trescot AM, Helm S, Hansen H, Benyamin R, G<strong>la</strong>ser SE, Ad<strong>la</strong>ka R, et al. Opioids in themanagement of chronic non-cancer pain: an update of American Society of theInterventional Pain Physicians’ (ASIPP) Gui<strong>de</strong>lines. Pain Physician. 2008;11(2Suppl):S5-S62.44. Wary B. Doloplus-2, une échelle pour <strong>la</strong> mesure <strong>de</strong> <strong>la</strong> <strong>douleur</strong>. Soins Gerontol.1999;19:25-7.45. Wolfe M.M., Lichtenstein D.R., Singh G. (1999). Gastrointestinal toxicityof nonsteroidal anti-inf<strong>la</strong>mmatory drugs. New Eng<strong>la</strong>nd Journal of Medicine,340, 1888-1899.<strong>DOULEUR</strong>S OSTÉO-ARTICULAIRES DE LA <strong>PERSONNE</strong> ÂGÉ147
Change language